Classification of Medicines

FDA will lift warnings on hormone therapy for menopause

FDA Removes Black-Box Warning for All Menopause Hormone Therapy Drugs

Major news in the women’s health world today: the Food and Drug Administration (FDA) just announced that it recommends drug manufacturers remove the black-box warning, the highest classification of wa...

· 1d

US FDA Asks Drugmakers to Remove Warnings From Hormone Therapy

· 1d

FDA reversing its stance on black box warnings for hormone therapy

· 11h

The FDA Removes a Long-Standing Warning From Hormone-Based Menopause Drugs

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Adm...

· 10h

FDA to remove ‘black box’ warning from hormone therapy for menopause

KSL · 1d

FDA to drop black box warnings from menopause hormone therapies

11don MSN

FDA says drug makers have recalled a blood pressure medicine tainted with a cancer-causing chemical

The U.S. Food and Drug Administration says drug makers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-caus

13don MSN

FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

It's the Trump administration's latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.

13d

US aims to quicken approvals for cheaper versions of complex drugs

The US Food and Drug Administration said Wednesday it would ease the approvals process for developing replicas of biologic drugs used to treat conditions including autoimmune diseases, cancer and diabetes.

13don MSN

FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The US Food and Drug Administration will take steps to streamline the process to develop generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate approvals for cheaper alternatives for medications used to treat a wide range of illnesses,